COMP-Growth Factor Complexes for Cartilage Repair

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current treatments for osteoarthritis focus on symptom relief rather than addressing the underlying pathology or improving cartilage and bone function, and there is a lack of effective solutions for pre-arthritic joint injuries that may lead to future osteoarthritis.

Innovation Solution

Development of protein complexes or scaffolds comprising cartilage oligomeric matrix protein (COMP) bound to one or more growth factors, such as TGF-β1, BMP-2, BMP-4, and BMP-7, to promote chondrogenesis and osteogenesis, which can be used to repair cartilage and bone lesions by enhancing the local concentration of growth factors at the site of injury.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If growth factors are administered systemically to treat osteoarthritis, then therapeutic coverage is achieved, but side effects increase and local concentration at injury site is insufficient

Engineering Contradiction:

Improvelocal concentration of growth factorsVSAvoidside effects of systemic administration

Core Design Contradiction:

Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent uses COMP protein as an intermediary carrier to bind growth factors (TGF-β1, BMPs) and deliver them locally to cartilage and bone lesions. This mediator approach allows the growth factors to be transported and released at the target site without requiring systemic circulation, thereby achieving high local concentration while avoiding systemic side effects.

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a localized therapeutic effect by forming COMP-growth factor complexes that concentrate the therapeutic agents precisely at the injury site. The complexes are designed to accumulate at cartilage and bone lesions, providing high local concentration of growth factors only where needed, rather than distributing them systemically throughout the body.

Inventive Principle:

Principle #3Local quality

2Reliability

If high doses of growth factors are used to achieve therapeutic effect, then biological activity is enhanced, but systemic exposure and side effects increase

Engineering Contradiction:

Improvebiological activity of growth factorsVSAvoidsystemic exposure to growth factors

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

COMP serves as a mediator that carries growth factors to the target tissue, allowing lower overall doses to achieve the same therapeutic effect. The carrier ensures that the growth factors are delivered efficiently to the lesion site, maintaining high biological activity without requiring high systemic doses that would cause side effects.

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the delivery parameter from systemic administration to localized delivery via COMP complexes. This parameter change allows the same biological activity to be achieved with lower total doses, as the growth factors are concentrated at the target site rather than distributed systemically.

Inventive Principle:

Principle #35Parameter changes

3Object-affected harmful factors

If current symptomatic treatments are used for osteoarthritis, then pain relief is achieved, but underlying pathology and cartilage function are not improved

Engineering Contradiction:

Improvepain symptomsVSAvoidcartilage function and pathology

Core Design Contradiction:

Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent takes preliminary action by addressing the underlying pathology of osteoarthritis through cartilage and bone repair, rather than merely treating symptoms. By using COMP-growth factor complexes to stimulate tissue regeneration and restore cartilage function, the treatment prevents further degradation and addresses the root cause, while also providing pain relief as a secondary benefit.

Inventive Principle:

Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The COMP-growth factor complexes effectively promote cartilage and bone repair by increasing the local concentration of growth factors, reducing the need for systemic administration and associated side effects, and enhancing the biological activity of TGF-β1 and BMPs, leading to improved tissue engineering applications and therapeutic outcomes.

Implementation Method 1

Cartilage Oligomeric Matrix Protein (COMP) is an important cartilage protein that is essential for the structural integrity of the cartilage extracellular matrix. COMP binds to matrix components including collagens, aggrecan, matrilin, fibronectin, and extracellular matrix protein-1 (ECM-1).

Methodology Applied

Scientific EffectProtein binding:

Data Source

PatentUS9133259B2Cartilage oligomeric matrix protein (COMP)—growth factor complexes and uses thereof

Publication Date: 2015.09.15 RGT UNIV OF CALIFORNIA

AI summary

The present invention relates to protein complexes or scaffold comprising cartilage oligomeric matrix protein (COMP) polypeptides bound to one or more growth factors, and methods of their use in promoting chondrogenesis and/or osteogenesis, and repair of cartilage and bone lesions.